Release Date: 29/07/11 18:42 Summary: 4th Quarter Cash Flow Report for the Period Ended 30 Jun 11 Price Sensitive: Yes Download Document 1.39MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%